1 study found for:    14737219 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma
Conditions: Esophageal Neoplasms;   Stomach Neoplasms;   Neoplasm Metastasis
Intervention: Drug: capecitabine (Xeloda), oxaliplatin and bevacizumab (Avastin)

Indicates status has not been verified in more than two years